Department of Surgery,
Faculty of Medicine,
Department of Surgery, Faculty of Medicine
Xiuhua Wang has not added Biography.
If you are Xiuhua Wang and would like to personalize this page please email our Author Liaison for assistance.
Loss of TIMP3 enhances interstitial nephritis and fibrosis.
Journal of the American Society of Nephrology : JASN Jun, 2009 | Pubmed ID: 19406980
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
American journal of physiology. Heart and circulatory physiology Dec, 2009 | Pubmed ID: 19801494
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Circulation. Heart failure Sep, 2009 | Pubmed ID: 19808375
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Circulation research Mar, 2010 | Pubmed ID: 20056917
Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
American journal of physiology. Heart and circulatory physiology Oct, 2010 | Pubmed ID: 20675565
Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Circulation Nov, 2011 | Pubmed ID: 21986284
Loss of Timp3 gene leads to abdominal aortic aneurysm formation in response to angiotensin II.
The Journal of biological chemistry Dec, 2012 | Pubmed ID: 23144462
TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
Cardiovascular research Jun, 2013 | Pubmed ID: 23524300
TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury.
Kidney international Jan, 2014 | Pubmed ID: 23760282
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Cardiovascular research Jul, 2014 | Pubmed ID: 24692173
Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4.
Circulation. Heart failure Jul, 2014 | Pubmed ID: 24842912
Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm.
Arteriosclerosis, thrombosis, and vascular biology Apr, 2015 | Pubmed ID: 25657308
Cardiomyocyte A Disintegrin And Metalloproteinase 17 (ADAM17) Is Essential in Post-Myocardial Infarction Repair by Regulating Angiogenesis.
Circulation. Heart failure Sep, 2015 | Pubmed ID: 26136458
Inhibition of Soluble Epoxide Hydrolase Limits Mitochondrial Damage and Preserves Function Following Ischemic Injury.
Frontiers in pharmacology , 2016 | Pubmed ID: 27375480
A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1.
Hypertension (Dallas, Tex. : 1979) 10, 2016 | Pubmed ID: 27550917
Genetic deletion of soluble epoxide hydrolase provides cardioprotective responses following myocardial infarction in aged mice.
Prostaglandins & other lipid mediators 09, 2017 | Pubmed ID: 28104457
Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction.
Hypertension (Dallas, Tex. : 1979) 06, 2017 | Pubmed ID: 28373589
Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
American journal of physiology. Heart and circulatory physiology Aug, 2017 | Pubmed ID: 28550172
Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption.
Scientific reports 07, 2017 | Pubmed ID: 28740132
Keir A. Forgie1,2,
Nicholas Fialka3,
Max Buchko1,2,
Sayed Himmat4,
Sanaz Hatami4,
Xiao Qi4,
Xiuhua Wang4,
Katie-Marie Buswell5,
Ryan Edgar5,
Darren H. Freed1,2,6,7,
Jayan Nagendran1,2,6,7
1Division of Cardiac Surgery, Department of Surgery, Faculty of Medicine, University of Alberta,
2, Mazankowski Alberta Heart Institute,
3Faculty of Medicine and Dentistry, University of Alberta,
4Department of Surgery, Faculty of Medicine, University of Alberta,
5Ray Rajotte Surgical-Medical Research Institute (SMRI), University of Alberta,
6, Alberta Transplant Institute,
7, Canadian Donation and Transplantation Research Program
Keir A. Forgie1,2,
Nicholas Fialka3,
Mubashir Khan4,
Max Buchko1,2,
Sanaz Hatami4,
Sayed Himmat4,
Xiao Qi4,
Xiuhua Wang4,
Katie-Marie Buswell5,
Ryan Edgar5,
Daina Domahidi5,
Darren H. Freed1,2,6,7,
Jayan Nagendran1,2,6,7
1Division of Cardiac Surgery, Department of Surgery, Faculty of Medicine, University of Alberta,
2, Mazankowski Alberta Heart Institute,
3Faculty of Medicine and Dentistry, University of Alberta,
4Department of Surgery, Faculty of Medicine, University of Alberta,
5Ray Rajotte Surgical-Medical Research Institute (SMRI), University of Alberta,
6, Alberta Transplant Institute,
7, Canadian Donation and Transplantation Research Program
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados